Hylenex injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Hylenex injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Hylenex
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hylenex injection-Insulin degludec
- Hylenex injection-Insulin Degludec (U-100) Prefilled Pens
- Hylenex injection-Insulin Degludec (U-100) Vials
- Hylenex injection-Insulin Degludec (U-200) Prefilled Pens
- Hylenex injection-Insulin degludec and liraglutide
- Hylenex injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Hylenex Recombinant
- Insulin aspart, recombinant Subcutaneous-Hylorel
- Insulin aspart, recombinant Subcutaneous-Hymovis
- Insulin aspart, recombinant Subcutaneous-Hyolev MB
- Insulin aspart, recombinant Subcutaneous-Hyolev MB Tablets
- Insulin aspart, recombinant Subcutaneous-HyoMax